Strategic Blueprint, LLC Exact Sciences Corp Transaction History

Strategic Blueprint, LLC

  • $1.54 Billion
  • Q4 2024

A detailed history of Strategic Blueprint, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Strategic Blueprint, LLC holds 5,559 shares of EXAS stock, worth $309,525. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,559
Previous 5,713 2.7%
Holding current value
$309,525
Previous $388,000 19.59%
% of portfolio
0.02%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025
SELL
$49.33 - $71.97 $7,596 - $11,083
-154 Reduced 2.7%
5,559 $312,000
Q3 2024

Oct 25, 2024
SELL
$42.43 - $70.83 $42 - $70
-1 Reduced 0.02%
5,713 $388,000
Q2 2024

Jul 26, 2024
SELL
$41.33 - $74.26 $6,364 - $11,436
-154 Reduced 2.62%
5,714 $241,000
Q1 2024

Apr 23, 2024
BUY
$56.27 - $73.77 $22,057 - $28,917
392 Added 7.16%
5,868 $405,000
Q4 2023

Jan 25, 2024
BUY
$59.06 - $75.72 $1,594 - $2,044
27 Added 0.5%
5,476 $405,000
Q3 2023

Oct 18, 2023
BUY
$65.94 - $99.04 $10,748 - $16,143
163 Added 3.08%
5,449 $371,000
Q2 2023

Oct 18, 2023
BUY
$62.68 - $95.05 $31,340 - $47,525
500 Added 10.45%
5,286 $496,000
Q4 2022

Jan 26, 2023
BUY
$30.35 - $53.15 $145,255 - $254,375
4,786 New
4,786 $0
Q2 2022

Aug 12, 2022
SELL
$35.61 - $76.23 $171,426 - $366,971
-4,814 Closed
0 $0
Q1 2022

Aug 12, 2022
SELL
$57.56 - $82.54 $17,555 - $25,174
-305 Reduced 5.96%
4,814 $337,000
Q4 2021

Feb 14, 2022
BUY
$72.5 - $100.68 $3,625 - $5,034
50 Added 0.99%
5,119 $398,000
Q3 2021

Nov 12, 2021
BUY
$90.24 - $124.05 $47,827 - $65,746
530 Added 11.68%
5,069 $484,000
Q2 2021

Aug 12, 2021
BUY
$93.66 - $139.27 $39,430 - $58,632
421 Added 10.22%
4,539 $564,000
Q1 2021

May 10, 2021
SELL
$116.57 - $155.01 $6,644 - $8,835
-57 Reduced 1.37%
4,118 $543,000
Q3 2020

Oct 27, 2020
BUY
$72.92 - $102.01 $20,053 - $28,052
275 Added 7.05%
4,175 $426,000
Q2 2020

Jul 20, 2020
BUY
$55.75 - $92.75 $15,164 - $25,228
272 Added 7.5%
3,900 $339,000
Q1 2020

Apr 20, 2020
BUY
$37.9 - $104.44 $3,790 - $10,444
100 Added 2.83%
3,628 $210,000
Q4 2019

Jan 10, 2020
BUY
$77.66 - $99.74 $231,038 - $296,726
2,975 Added 537.97%
3,528 $326,000
Q3 2019

Oct 16, 2019
BUY
$90.37 - $122.49 $49,974 - $67,736
553 New
553 $50,000

Others Institutions Holding EXAS

# of Institutions
666
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.85B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Strategic Blueprint, LLC Portfolio

Follow Strategic Blueprint, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Blueprint, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email